日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Older breast cancer survivors' exercise and support group program experiences and recommendations from the IMPROVE trial: a qualitative study

来自 IMPROVE 试验的老年乳腺癌幸存者运动和支持小组项目经验及建议:一项定性研究

Hundal, Jasmin; Williams, Dionne; Nock, Nora L; Austin, Kristina; Bennet, Elizabeth; Cerne, Stephen; Moore, Halle C F; Petkac, Jean; Schmitz, Kathryn H; Berger, Nathan A; Owusu, Cynthia

Exercise and Nutrition to Improve Cancer Treatment-Related Outcomes (ENICTO)

运动与营养改善癌症治疗相关结果(ENICTO)

Schmitz, Kathryn H; Brown, Justin C; Irwin, Melinda L; Robien, Kim; Scott, Jessica M; Berger, Nathan A; Caan, Bette; Cercek, Andrea; Crane, Tracy E; Evans, Scott R; Ligibel, Jennifer A; Meyerhardt, Jeffrey A; Agurs-Collins, Tanya; Basen-Engquist, Karen; Bea, Jennifer W; Cai, Sheng F; Cartmel, Brenda; Chinchilli, Vernon M; Demark-Wahnefried, Wendy; Dieli-Conwright, Christina M; DiPietro, Loretta; Doerksen, Shawna E; Edelstein, Sharon L; Elena, Joanne; Evans, William; Ferrucci, Leah M; Foldi, Julia; Freylersythe, Sarah; Furberg, Helena; Jones, Lee W; Levine, Ross; Moskowitz, Chaya S; Owusu, Cynthia; Penedo, Frank; Rabin, Borsika A; Ratner, Elena; Rosenzweig, Margaret; Salz, Talya; Sanft, Tara; Schlumbrecht, Matthew; Spielmann, Guillaume; Thomson, Cynthia A; Tjaden, Ashley H; Weiser, Martin R; Yang, Shengping; Yu, Anthony F; Perna, Frank M

SAT-041 Prevalence and Clinical Presentation of Multiple Endocrine Neoplasia (MEN-1) in Aotearoa New Zealand; a FERNZ Registry Study

SAT-041 新西兰多发性内分泌肿瘤 (MEN-1) 的患病率和临床表现:一项 FERNZ 注册研究

Thompson, Cheryl L; Berger, Nathan A; Chak, Amitabh; Li, Li; Niyagama, Anjana; Elston, Marianne; Boyle, Veronica; Corley, Brian; Walsh, Emily; Yeoh, Joey; Tamatea, Jade; Soule, Steven G; Wei Yong, King; Park, William; William Carroll, Richard

TeleHealth Resistance exercise Intervention to preserve dose intensity and Vitality in Elder Breast Cancer Patients (THRIVE 65)

远程医疗阻力训练干预以维持老年乳腺癌患者的剂量强度和活力(THRIVE 65)

Schmitz, Kathryn H; Berger, Nathan A; Owusu, Cynthia; Thomson, Cynthia A; Chinchilli, Vernon M; Basen-Engquist, Karen; Evans, William J; Pink, John J; Schleicher, Erica A; Cao, Chao; Doerksen, Shawna E; Binder, Jenna D; Sobolewski, Michele D; Tanasijevic, Anna M; Diguglielmo, Kaedryn A; Nguyen, Truong L; Mills, Carissa A; Kemp, Wendy; Oppenheim, Jay B; Ligibel, Jennifer A

Association of semaglutide with risk of suicidal ideation in a real-world cohort

在真实世界队列研究中,司美格鲁肽与自杀意念风险的关联

Wang, William; Volkow, Nora D; Berger, Nathan A; Davis, Pamela B; Kaelber, David C; Xu, Rong

Association of GLP-1 Receptor Agonists and Hepatocellular Carcinoma Incidence and Hepatic Decompensation in Patients With Type 2 Diabetes

GLP-1受体激动剂与2型糖尿病患者肝细胞癌发生率和肝功能失代偿的相关性

Wang, Lindsey; Berger, Nathan A; Kaelber, David C; Xu, Rong

GLP-1 Receptor Agonists and Colorectal Cancer Risk in Drug-Naive Patients With Type 2 Diabetes, With and Without Overweight/Obesity

GLP-1受体激动剂与未接受药物治疗的2型糖尿病患者(伴或不伴超重/肥胖)结直肠癌风险

Wang, Lindsey; Wang, William; Kaelber, David C; Xu, Rong; Berger, Nathan A

Associations of semaglutide with incidence and recurrence of alcohol use disorder in real-world population

司美格鲁肽与真实世界人群中酒精使用障碍的发生率和复发率之间的关联

Wang, William; Volkow, Nora D; Berger, Nathan A; Davis, Pamela B; Kaelber, David C; Xu, Rong

Association of Semaglutide With Tobacco Use Disorder in Patients With Type 2 Diabetes : Target Trial Emulation Using Real-World Data

司美格鲁肽与2型糖尿病患者烟草使用障碍的关联:基于真实世界数据的Target试验模拟

Wang, William; Volkow, Nora D; Berger, Nathan A; Davis, Pamela B; Kaelber, David C; Xu, Rong

Association of semaglutide with reduced incidence and relapse of cannabis use disorder in real-world populations: a retrospective cohort study

在真实世界人群中,司美格鲁肽与大麻使用障碍发生率和复发率降低的相关性:一项回顾性队列研究

Wang, William; Volkow, Nora D; Berger, Nathan A; Davis, Pamela B; Kaelber, David C; Xu, Rong